Press Releases

09 Mar

Uncategorized

EASTGATE ACQUISITIONS ANNOUNCES COMPLETION OF PRIVATE EQUITY INVESTMENT FINANCING

• March 9, 2022
• By admin
• 0 comments

SALT LAKE CITY and TORONTO, Mar. 10, 2014 /PRNewswire/ —  EastGate Acquisitions Corporation (OTCBB:  ESAQ), an emerging pharmaceuti...

Continue reading

09 Mar

Uncategorized

EASTGATE ACQUISITIONS PRESENTS AN INTRODUCTION TO ITS SELF-EMULSIFYING PLATFORM DELIVERY SYSTEM FOR ENHANCING BIOAVAILABILITY OF BIOLOGICALLY ACTIVE COMPOUNDS

• March 9, 2022
• By admin
• 0 comments

SALT LAKE CITY and TORONTO, May 20, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical...

Continue reading

09 Mar

Uncategorized

EASTGATE ACQUISITIONS ANNOUNCES PRESENTATION AT STE’S 3 ANNUAL MICROCAP INVESTOR CONFERENCE

• March 9, 2022
• By admin
• 0 comments

SALT LAKE CITY and TORONTO, May 28, 2014 /PRNewswire/ —  EastGate Acquisitions Corporation (OTCBB:  ESAQ), an emerging pharmaceut...

Continue reading

09 Mar

Uncategorized

EASTGATE ACQUISITIONS ENTERS INTO WORKING COLLABORATION WITH LEADING NEUROLOGIST AT TORONTO WESTERN HOSPITAL

• March 9, 2022
• By admin
• 0 comments

SALT LAKE CITY and TORONTO, June 17, 2014 /PRNewswire/ —  EastGate Acquisitions Corporation (OTCBB:  ESAQ), an emerging pharmaceuti...

Continue reading

09 Mar

Uncategorized

EASTGATE ACQUISITIONS RECEIVES RESEARCH GRANT FROM ONTARIO BRAIN INSTITUTE

• March 9, 2022
• By admin
• 0 comments

SALT LAKE CITY and TORONTO, June 25, 2014 /PRNewswire/– EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical...

Continue reading

09 Mar

Uncategorized

EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology

• March 9, 2022
• By admin
• 0 comments

New pharmaceutical development opens up entry into blockbuster markets SALT LAKE CITY and TORONTO, July 29, 2014 /PRNewswire/ — ...

Continue reading

09 Mar

Uncategorized

A transmucosal Lorazepam spray for treatment of acute seizures: Summary

• March 9, 2022
• By admin
• 0 comments

A transmucosal Lorazepam spray for treatment of acute seizures: Summary The estimated annual incidence of prolonged epileptic se...

Continue reading

09 Mar

Uncategorized

EASTGATE ACQUISITIONS ENTERS INTO A LICENSE AGREEMENT WITH PURINE PHARMA LLC FOR MARKETING AND DISTRIBUTION OF ITS NUTRACEUTICAL AND CONSUMER PRODUCT LINE

• March 9, 2022
• By admin
• 0 comments

SALT LAKE CITY and TORONTO, September 29, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmace...

Continue reading

09 Mar

Uncategorized

EASTGATE ACQUISITIONS AUGMENTS ITS SUB-MICRON SELF-NANOEMULSIFYING PLATFORM TECHNOLOGY

• March 9, 2022
• By admin
• 0 comments

Broad spectrum of delivery forms is directed towards improving patient compliance SALT LAKE CITY and TORONTO, August 15 , 2014 (...

Continue reading

09 Mar

Uncategorized

Company’s Proprietary Intraoral Lorazepam Spray

• March 9, 2022
• By admin
• 0 comments

SALT LAKE CITY and TORONTO, November 3, 2014 (PRNewswire/-) EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceut...

Continue reading